Citius Pharmaceuticals Inc (CTXR)
0.1345
-0.03
(-18.53%)
USD |
NASDAQ |
Nov 22, 16:00
0.1301
0.00 (0.00%)
After-Hours: 16:04
Citius Pharmaceuticals Max Drawdown (5Y): 98.88% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.88% |
| September 30, 2024 | 98.88% |
| August 31, 2024 | 98.88% |
| July 31, 2024 | 98.88% |
| June 30, 2024 | 98.88% |
| May 31, 2024 | 98.88% |
| April 30, 2024 | 98.88% |
| March 31, 2024 | 98.88% |
| February 29, 2024 | 98.88% |
| January 31, 2024 | 98.88% |
| December 31, 2023 | 98.88% |
| November 30, 2023 | 98.88% |
| October 31, 2023 | 98.88% |
| September 30, 2023 | 98.88% |
| August 31, 2023 | 98.88% |
| July 31, 2023 | 98.88% |
| June 30, 2023 | 98.88% |
| May 31, 2023 | 98.88% |
| April 30, 2023 | 98.88% |
| March 31, 2023 | 98.88% |
| February 28, 2023 | 98.88% |
| January 31, 2023 | 98.88% |
| December 31, 2022 | 98.88% |
| November 30, 2022 | 98.88% |
| October 31, 2022 | 98.88% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.88% |
| August 31, 2022 | 98.88% |
| July 31, 2022 | 98.88% |
| June 30, 2022 | 98.88% |
| May 31, 2022 | 98.88% |
| April 30, 2022 | 98.88% |
| March 31, 2022 | 98.88% |
| February 28, 2022 | 98.88% |
| January 31, 2022 | 98.88% |
| December 31, 2021 | 98.88% |
| November 30, 2021 | 98.88% |
| October 31, 2021 | 98.88% |
| September 30, 2021 | 98.88% |
| August 31, 2021 | 98.88% |
| July 31, 2021 | 98.88% |
| June 30, 2021 | 98.88% |
| May 31, 2021 | 98.88% |
| April 30, 2021 | 98.88% |
| March 31, 2021 | 98.88% |
| February 28, 2021 | 98.88% |
| January 31, 2021 | 98.88% |
| December 31, 2020 | 98.88% |
| November 30, 2020 | 98.88% |
| October 31, 2020 | 98.88% |
| September 30, 2020 | 98.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.85%
Minimum
Nov 2019
98.88%
Maximum
Dec 2019
98.88%
Average
98.88%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
| Citius Oncology Inc | -- |
| Agilent Technologies Inc | 42.74% |
| Merck & Co Inc | 27.26% |
| Cara Therapeutics Inc | 99.17% |
| Moleculin Biotech Inc | 98.40% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -30.93 |
| Beta (5Y) | 1.659 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.39% |
| Historical Sharpe Ratio (5Y) | -0.1064 |
| Historical Sortino (5Y) | -0.2205 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.67% |